Loading clinical trials...
Loading clinical trials...
PROGENI (Parkinson's Research: The Organized Genetics Initiative) Family Study
The PROGENI Family Study is part of a larger consortium that is studying a gene shown to be important in Parkinson's disease, called LRRK2. People who have a defect in the LRRK2 gene will often develop Parkinson's disease. Eligible participants will be asked to complete a single Study Visit at an affiliated research facility closest to their home.
Participants will be asked to complete a family history questionnaire, which will gather information about their family history of Parkinson's disease and related disorders. They will be asked to complete a single Study Visit, during which they will be asked to do some or all of the following: 1. Complete questionnaires regarding Parkinson's disease symptoms, medical history, mood, sleep, mental status, and activity level. 2. Be given a brief standard neurological examination. 3. Be given a scratch and sniff smell identification test. 4. Be asked to give a sample of approximately 2 tablespoons of blood. 5. Be asked to give a urine sample of approximately 1 tablespoon of urine.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Cleveland Clinic Florida
Weston, Florida, United States
Indiana University Medical Center
Indianapolis, Indiana, United States
University of Iowa Hospitals
Iowa City, Iowa, United States
Kansas University Medical Center
Kansas City, Kansas, United States
University of Maryland School of Medicine
Baltimore, Maryland, United States
University of Nebraska
Omaha, Nebraska, United States
Beth Israel Medical Center
New York, New York, United States
Medical University of Ohio
Toledo, Ohio, United States
Oregon Health & Science University
Portland, Oregon, United States
University of Alberta
Edmonton, Alberta, Canada
Start Date
May 1, 2011
Primary Completion Date
December 1, 2013
Completion Date
December 1, 2013
Last Updated
December 16, 2013
81
ACTUAL participants
Lead Sponsor
Indiana University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06113640